Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Lainie Jones Comprehensive Cancer Survivorship Act of 2026
Client: LYMPHOMA RESEARCH FOUNDATION · Firm: TURNER & GOSS LLP
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839
Lainie Jones Comprehensive Cancer Survivorship Act of 2026
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839/S 5052
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2026 · third_quarter · Q3
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839/S 5052
Filing targets: HOUSE OF REPRESENTATIVES
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2026 · third_quarter · Q3
Source: Senate LDA
| American Society of Clinical Oncology, Inc. |
| 3 |
| 2007–2008 |
| FOOD ALLERGY RESEARCH & EDUCATION | 3 | 2014 |
Lainie Jones Comprehensive Cancer Survivorship Act of 2026
Client: LYMPHOMA RESEARCH FOUNDATION · Firm: TURNER & GOSS LLP
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839/S 5052
Lainie Jones Comprehensive Cancer Survivorship Act of 2026
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839
Lainie Jones Comprehensive Cancer Survivorship Act of 2026
Client: LYMPHOMA RESEARCH FOUNDATION · Firm: TURNER & GOSS LLP
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839/S 5052
Lainie Jones Comprehensive Cancer Survivorship Act of 2026
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839/S 5052
Legislative Branch Appropriations Act, 2024
Client: LYMPHOMA RESEARCH FOUNDATION · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 4364/S2213
Legislative Branch Appropriations Act, 2024
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 4364/S2213
Legislative Branch Appropriations Act, 2024
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act (HR 4364/S 2213)
Legislative Branch Appropriations Act, 2024
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 4364/S2213 Breast reconstruction surgery third-party coverage and payment issues
Legislative Branch Appropriations Act, 2024
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 4364/S 2213 21st Century Cures Act report from Representatives DeGette and Bucshon
Legislative Branch Appropriations Act, 2024
Client: LYMPHOMA RESEARCH FOUNDATION · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act (HR 4364/S 2213)
Comprehensive Cancer Survivorship Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 4364/S2213
Comprehensive Cancer Survivorship Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act (HR 4364/S 2213)
Comprehensive Cancer Survivorship Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 4364/S2213 Breast reconstruction surgery third-party coverage and payment issues
Comprehensive Cancer Survivorship Act
Client: LYMPHOMA RESEARCH FOUNDATION · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 4364/S2213
Comprehensive Cancer Survivorship Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 4364/S 2213 21st Century Cures Act report from Representatives DeGette and Bucshon
Comprehensive Cancer Survivorship Act
Client: LYMPHOMA RESEARCH FOUNDATION · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act (HR 4364/S 2213)
PASTEUR Act of 2023 (S 1355 and HR 2940)
Legislative Branch Appropriations Act, 2024
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 4364/S2213 Cancer Care Planning and Communications Act, HR 5183
Legislative Branch Appropriations Act, 2024
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR4364 and S 2213 Cancer Care Planning and Communications Act (HR 4414 in 117th; under development in 118th)
Cancer Care Planning and Communications Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 4364/S2213 Cancer Care Planning and Communications Act, HR 5183
PASTEUR Act of 2023 (S 1355 and HR 2940)
Comprehensive Cancer Survivorship Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 4364/S2213 Cancer Care Planning and Communications Act, HR 5183
Comprehensive Cancer Survivorship Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR4364 and S 2213 Cancer Care Planning and Communications Act (HR 4414 in 117th; under development in 118th)
Cancer Care Planning and Communications Act of 2021
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR4364 and S 2213 Cancer Care Planning and Communications Act (HR 4414 in 117th; under development in 118th)
Comprehensive Cancer Survivorship Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 9565
Consolidated Appropriations Act, 2023
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
Medicare payment issues included in HR 2617, Consolidated Appropriations Act
Cancer Care Planning and Communications Act of 2021
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Cancer Care Planning and Communications Act of 2021, HR 4414 Cancer survivorship legislation under development by Representative Wasserman Schultz
Comprehensive Cancer Survivorship Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Survivorship Act, HR 9565.
HEROES Act (HR 6800) paid leave provisions
Paid leave for individuals at risk of COVID-19, HEROES Act (HR6800) and revised HEROES Act (HR 8406)
Response to HELP Committee Chair Lamar Alexander request for information on pandemic preparedness HEROES Act (HR 6800) provisions related to paid leave
HEROES Act (HR 6800), paid leave provisions Comments to HELP Committee Chair Lamar Alexander in response to request for information on pandemic preparedness
Making emergency supplemental appropriations for the fiscal year ending September 30, 2021, and for other purposes.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: TURNER & GOSS LLP
Paid leave for individuals at risk of COVID-19, HEROES Act (HR6800) and revised HEROES Act (HR 8406)
Elijah E. Cummings Lower Drug Costs Now Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: TURNER & GOSS LLP
S 2543, Prescription Drug Pricing Reduction Act HR 3, Lower Drug Costs Now Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: TURNER & GOSS LLP
HR 3, Elijah E. Cummings Lower Drug Costs Now Act
HR 913, CLINICAL TREATMENT Act S. 1895, Lower Health Care Costs Act
HR 913, CLINICAL TREATMENT Act S. 1895, Lower Health Care Costs Act
Prescription Drug Pricing Reduction Act of 2019
Client: CYSTIC FIBROSIS FOUNDATION · Firm: TURNER & GOSS LLP
S 2543, Prescription Drug Pricing Reduction Act HR 3, Lower Drug Costs Now Act
HR 3325/S 428, ACE Kids Act
Cancer Care Planning and Communications Act of 2018
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
HR 5160, Cancer Care Planning and Communications Act
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
HR 5247/S 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017
HR 6826, CLINICAL Treatment Act
Maintaining Protections for Patients with Preexisting Conditions Act of 2018
Client: CYSTIC FIBROSIS FOUNDATION · Firm: TURNER & GOSS LLP
HR 6898, Maintaining Protections for Patients with Preexisting Conditions Act
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
HR 5247/S 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
S. 204/P.L. 115-176, Right to Try Act of 2017
HR 3325/S 428, ACE Kids Act
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: TURNER & GOSS LLP
Repeal of Affordable Care Act individual mandate in the Tax Cuts and Jobs Act, HR 1 Bipartisan Health Care Stabilization Act of 2017
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
Repeal of the Affordable Care Act individual mandate in the Tax Cuts and Jobs Act, HR 1 Bipartisan Health Care Stabilization Act of 2017
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Repeal of the Affordable Care Act individual mandate in the Tax Cuts and Jobs Act, HR 1 Bipartisan Health Care Stabilization Act of 2017
American Health Care Act of 2017
Client: CYSTIC FIBROSIS FOUNDATION · Firm: TURNER & GOSS LLP
HR 1628, American Health Care Act, and Graham-Cassidy amendment
American Health Care Act of 2017
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
American Health Care Act, HR 1628
American Health Care Act of 2017
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
American Health Care Act, HR 1628
American Health Care Act of 2017
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
HR 1628, American Health Care Act Better Care Reconciliation Act
American Health Care Act of 2017
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
HR 1628, American Health Care Act Better Care Reconciliation Act
American Health Care Act of 2017
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
HR 1628, American Health Care Act, and Graham-Cassidy amendment
American Health Care Act of 2017
Client: CYSTIC FIBROSIS FOUNDATION · Firm: TURNER & GOSS LLP
HR 1628, American Health Care Act Better Care Reconciliation Act
American Health Care Act of 2017
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
HR 1628, American Health Care Act, and Graham-Cassidy Amendment
American Health Care Act of 2017
Client: CYSTIC FIBROSIS FOUNDATION · Firm: TURNER & GOSS LLP
American Health Care Act, H.R. 1628
Planning Actively for Cancer Treatment (PACT) Act of 2015
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
HR 2846, Planning Actively for Cancer Treatment Act
Planning Actively for Cancer Treatment (PACT) Act of 2015
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
HR 2846, Planning Actively for Cancer Treatment Act
Consolidated Appropriations Act, 2016
Client: CYSTIC FIBROSIS FOUNDATION · Firm: TURNER & GOSS LLP
Funding for the National Institutes of Health and Food and Drug Administration, H.R. 2029, Fiscal Year 2016 Consolidated Appropriations
Planning Actively for Cancer Treatment (PACT) Act of 2015
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Planning Actively for Cancer Treatment Act (HR 2846) and submission of comments to Senate Finance Committee regarding chronic care management in Medicare.
Planning Actively for Cancer Treatment (PACT) Act of 2015
Client: LYMPHOMA RESEARCH FOUNDATION · Firm: TURNER & GOSS LLP
Planning Actively for Cancer Treatment (PACT) Act, HR 2846 and submission of comments to Senate Finance Committee in response to request for information on chronic care management in Medicare.
Childhood Cancer STAR Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
21st Century Cures Act, HR 6 Childhood Cancer STAR Act, S 1883 and HR 3381
HR 6, 21st Century Cures Act
21st Century Cures Act, HR 6
21st Century Cures Act, HR 6
21st Century Cures Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
21st Century Cures Act, HR 6 Childhood Cancer STAR Act, S 1883 and HR 3381
H.R. 6, 21st Century Cures Act
21st Century Cures Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
H.R. 6, 21st Century Cures Act
Childhood Cancer STAR Act
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
21st Century Cures Act, HR 6 Childhood Cancer STAR Act, S 1883 and HR 3381
Medical Innovation Act, S. 320
Planning Actively for Cancer Treatment (PACT) Act of 2013
Client: LYMPHOMA RESEARCH FOUNDATION · Firm: TURNER & GOSS LLP
Planning Actively for Cancer Treatment Act, HR 2477
Planning Actively for Cancer Treatment (PACT) Act of 2013
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Planning Actively for Cancer Treatment Act, HR 2477 SGR Repeal & Medicare Provider Payment Modernization Act of 2014, S 2000/HR 4015
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Planning Actively for Cancer Treatment Act, HR 2477 SGR Repeal & Medicare Provider Payment Modernization Act of 2014, S 2000/HR 4015
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
SGR Repeal & Medicare Provider Payment Modernization Act, S 2000/HR4015
Expressing support for the designation of May 11, 2014, through May 17, 2014, as Food Allergy Awareness Week.
Client: FOOD ALLERGY RESEARCH & EDUCATION · Firm: TURNER & GOSS LLP
H Res 584, Food Allergy Awareness Week Resolution
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
SGR Repeal & Medicare Provider Payment Modernization Act, S 2000/HR4015
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Planning Actively for Cancer Treatment Act, HR 2477 SGR Repeal & Medicare Provider Payment Modernization Act of 2014, S 2000/HR 4015
Safeguarding America's Pharmaceuticals Act of 2013
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
S. 957, Drug Supply Chain Security Act H.R. 1919, Safeguarding America's Pharmaceuticals Act
Planning Actively for Cancer Treatment (PACT) Act of 2013
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
HR 2477, Planning Actively for Cancer Treatment Act
Planning Actively for Cancer Treatment (PACT) Act of 2013
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
H.R. 2477, the Planning Actively for Cancer Treatment Act (PACT Act)
Planning Actively for Cancer Treatment (PACT) Act of 2013
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
H.R. 2477, Planning Actively for Cancer Treatment Act
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 HR 2810, Medicare Patient Access and Quality Improvement Act
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: CANCER LEADERSHIP COUNCIL · Firm: TURNER & GOSS LLP
S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013 HR 2810, Medicare Patient Access and Quality Improvement Act
S. 957, Drug Supply Chain Security Act H.R. 1919, Safeguarding America's Pharmaceuticals Act
S. 957, Drug Supply Chain Security Act
Comprehensive Cancer Care Improvement Act of 2011
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
HR 3705/S. 2097, Comprehensive Cancer Care Improvement Act
Comprehensive Cancer Care Improvement Act of 2011
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Establishment of Medicare cancer care planning service through Comprehensive Cancer Care Improvement Act (S. 2097/HR 3705)
Comprehensive Cancer Care Improvement Act of 2011
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Care Improvement Act, S. 2097/HR 3705
Food and Drug Administration Safety and Innovation Act, including provisions of the Expanding and Promoting Exertise in Review of Rare Treatments Act of 2012 (S. 2281/HR 4156) as incorporated in the Act
Legislation reauthorizing the Prescription Drug User Fee Act S.2281/HR 4156, Expanding and Promoting Expertise in Review of Rare Treatments Act
Preserving Access to Life-Saving Medications Act of 2011
Client: LEUKEMIA & LYMPHOMA SOCIETY · Firm: TURNER & GOSS LLP
Preserving Access to Life-Saving Medications Acxt, S 296/HR 2245
Comprehensive Cancer Care Improvement Act of 2011
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Care Improvement Act, HR 3705
Comprehensive Cancer Care Improvement Act of 2009
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Care Improvement Act, HR 1844/S 1773
Comprehensive Cancer Care Improvement Act of 2009
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Care Improvement Act, HR 1844/S 1773
Comprehensive Cancer Care Improvement Act of 2009
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Care Improvement Act, HR 1844/S 1773
Comprehensive Cancer Care Improvement Act of 2009
Client: NATIONAL COALITION FOR CANCER SURVIVORSHIP · Firm: TURNER & GOSS LLP
Comprehensive Cancer Care Improvement Act, HR 1844/S 1773
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839/S 5052
Filing targets: HOUSE OF REPRESENTATIVES
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2026 · second_quarter · Q2
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2026 · second_quarter · Q2
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2026 · second_quarter · Q2
FY 2027 appropriations for National Institutes of Health and Centers for Disease Control and Prevention
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2026 · first_quarter · Q1
Provide comment on Comprehensive Cancer Survivorship Act, to be reintroduced in 119th Congress.
Filing targets: HOUSE OF REPRESENTATIVES
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2026 · first_quarter · Q1
Provide comment on Comprehensive Cancer Survivorship Act, to be reintroduced in 119th Congress.
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2025 · fourth_quarter · Q4
Provide input on Comprehensive Cancer Survivorship Act, to be reintroduced in 119th Congress.
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2025 · third_quarter · Q3
Provide input regarding Comprehensive Cancer Survivorship Act, to be reintroduced in 119th Congress.
Filing targets: HOUSE OF REPRESENTATIVES
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2025 · third_quarter · Q3
Provide input regarding the Comprehensive Cancer Survivorship Act, to be reintroduced in 119th Congress.
Filing targets: HOUSE OF REPRESENTATIVES
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2025 · third_quarter · Q3
Statement to Senate Finance Committee on operations of the Centers for Disease Control and Prevention.
Filing targets: SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2025 · second_quarter · Q2
Comprehensive Cancer Survivorship Act (to be reintroduced)
Filing targets: HOUSE OF REPRESENTATIVES
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2025 · second_quarter · Q2
Comprehensive Cancer Survivorship Act (to be reintroduced)
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2025 · first_quarter · Q1
Reintroduction of Comprehensive Cancer Survivorship Act and reintroduction of Cancer Care Planning and Communications Act.
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2024 · fourth_quarter · Q4
Comprehensive Cancer Survivorship Act, HR 4364/S 2213 21st Century Cures Act report from Representatives DeGette and Bucshon
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2024 · third_quarter · Q3
Comprehensive Cancer Survivorship Act, HR 4364/S2213
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2024 · second_quarter · Q2
Comprehensive Cancer Survivorship Act (HR 4364/S 2213)
Filing targets: HOUSE OF REPRESENTATIVES
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2024 · second_quarter · Q2
Comprehensive Cancer Survivorship Act (HR 4364/S 2213)
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2024 · first_quarter · Q1
Comprehensive Cancer Survivorship Act, HR 4364/S2213 Breast reconstruction surgery third-party coverage and payment issues
Filing targets: HOUSE OF REPRESENTATIVES
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2024 · first_quarter · Q1
Comprehensive Cancer Survivorship Act, HR 4364/S2213
Filing targets: HOUSE OF REPRESENTATIVES
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2023 · fourth_quarter · Q4
Endorsement of Dr. Monica Bertagnolli as National Institutes of Health Director
Filing targets: SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2023 · fourth_quarter · Q4
Comprehensive Cancer Survivorship Act, HR 9565
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2023 · third_quarter · Q3
Comprehensive Cancer Survivorship Act, HR 4364/S2213 Cancer Care Planning and Communications Act, HR 5183
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2023 · second_quarter · Q2
Comprehensive Cancer Survivorship Act, HR4364 and S 2213 Cancer Care Planning and Communications Act (HR 4414 in 117th; under development in 118th)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2023 · second_quarter · Q2
PASTEUR Act of 2023 (S 1355 and HR 2940)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2023 · first_quarter · Q1
Comprehensive Cancer Survivorship Act (to be reintroduced in new Congress)
Filing targets: HOUSE OF REPRESENTATIVES
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2023 · first_quarter · Q1
PASTEUR Act (HR 3932 and S 2076 in previous Congress; to be reintroduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2022 · fourth_quarter · Q4
Comprehensive Cancer Survivorship Act, HR 9565.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2022 · fourth_quarter · Q4
Incentives for development of antibiotics, including PASTEUR Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2022 · fourth_quarter · Q4
Medicare payment issues included in HR 2617, Consolidated Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2022 · third_quarter · Q3
Provide input regarding survivorship legislation under development by Representative Wasserman Schultz.
Filing targets: HOUSE OF REPRESENTATIVES
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2022 · third_quarter · Q3
Reforms to Medicare Part D prescription drug benefit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2022 · second_quarter · Q2
Provide input into the development of cancer survivorship legislation by Representative Debbie Wasserman Schultz.
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2022 · first_quarter · Q1
Cancer Care Planning and Communications Act of 2021, HR 4414 Cancer survivorship legislation under development by Representative Wasserman Schultz
Filing targets: HOUSE OF REPRESENTATIVES
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2022 · first_quarter · Q1
Cancer Survivorship legislation under development by Representative Wasserman Schultz Standards for distribution and use of monoclonal antibodies and antiviral treatments for the immune compromised
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2021 · fourth_quarter · Q4
Provide information as requested regarding cancer survivorship legislation being developed by Representative Wasserman Schultz.
Filing targets: HOUSE OF REPRESENTATIVES
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2021 · fourth_quarter · Q4
Provide information as requested related to cancer survivorship legislation being developed by Representative Wasserman Schultz.
Filing targets: HOUSE OF REPRESENTATIVES
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2021 · third_quarter · Q3
Provide advice on the organizational structure and mission of the Advanced Research Project Agency for Health (ARPA-H).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2021 · third_quarter · Q3
Advice on the structure and financing of the Advanced Research Projects Agency for Health (ARPA-H).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2021 · second_quarter · Q2
Development of cancer survivorship legislation to be introduced by Representative Wasserman Schultz.
Filing targets: HOUSE OF REPRESENTATIVES
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2021 · second_quarter · Q2
Development of cancer survivorship legislation to be introduced by Representative Wasserman Schultz.
Filing targets: HOUSE OF REPRESENTATIVES
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2021 · first_quarter · Q1
Communication with Advisory Committee on Immunization Practices regarding COVID vaccination priority for cancer patients.
Letter to HHS urging reversal of Trump Administration protected classes policy in Medicare Part D. Letter to HHS urging review of Radiation Oncology alternative payment model.
Filing targets: Centers For Disease Control & Prevention (CDC), Health & Human Services, Dept of (HHS)
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2021 · first_quarter · Q1
Development of cancer survivorship legislation by Representative Wasserman Schultz
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2020 · fourth_quarter · Q4
Cancer survivorship legislation being developed by Representative Debbie Wasserman Schultz.
Filing targets: HOUSE OF REPRESENTATIVES
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2020 · fourth_quarter · Q4
Distribution and allocation of COVID-19 vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2020 · third_quarter · Q3
Paid leave for individuals at risk of COVID-19, HEROES Act (HR6800) and revised HEROES Act (HR 8406)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2020 · second_quarter · Q2
Response to HELP Committee Chair Lamar Alexander request for information on pandemic preparedness HEROES Act (HR 6800) provisions related to paid leave
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2020 · second_quarter · Q2
HEROES Act (HR 6800) paid leave provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2020 · second_quarter · Q2
HEROES Act (HR 6800), paid leave provisions Comments to HELP Committee Chair Lamar Alexander in response to request for information on pandemic preparedness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2020 · first_quarter · Q1
Paid leave and unemployment insurance provisions of the Families First coronavirus package
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2020 · first_quarter · Q1
Statement of opposition to Trump Administration Medicaid block grant guidance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2020 · first_quarter · Q1
Legislation to improve the quality of care for cancer survivors, under development by Representative Debbie Wasserman Schultz
Filing targets: HOUSE OF REPRESENTATIVES
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2020 · first_quarter · Q1
Legislation to improve quality of care for cancer survivors, under development by Representative Debbie Wasserman Schultz
Filing targets: HOUSE OF REPRESENTATIVES
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2019 · fourth_quarter · Q4
Nomination of Food and Drug Administration Commissioner candidate Stephen Hahn Cures 2.0 initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2019 · fourth_quarter · Q4
HR 3, Elijah E. Cummings Lower Drug Costs Now Act
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2019 · third_quarter · Q3
Draft legislation to improve the quality of cancer survivorship care in the Medicare program.
Filing targets: HOUSE OF REPRESENTATIVES
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2019 · third_quarter · Q3
S 2543, Prescription Drug Pricing Reduction Act HR 3, Lower Drug Costs Now Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2019 · third_quarter · Q3
HR 913, CLINICAL TREATMENT Act S. 1895, Lower Health Care Costs Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2019 · second_quarter · Q2
The provisions of the Affordable Care Act that protect people with preexisting conditions and legislative proposals to strengthen or undermine those ACA provisions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2019 · second_quarter · Q2
Submit comments to Congress on proposals to strengthen Medicare Part D protections related to beneficiary cost-sharing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2019 · first_quarter · Q1
Letter responding to Senator Lamar Alexander's request for ideas to reduce health care expenditures
Filing targets: SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2019 · first_quarter · Q1
Proposals to improve the quality of cancer survivorship care Letter in response to Senator Lamar Alexander's request for ideas to reduce health care expenditures
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2019 · first_quarter · Q1
Protections for people with pre-existing conditions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2018 · fourth_quarter · Q4
Preexisting condition protection legislation and draft cancer survivorship legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2018 · fourth_quarter · Q4
HR 6898, Maintaining Protections for Patients with Preexisting Conditions Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2018 · fourth_quarter · Q4
HR 6826, CLINICAL Treatment Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2018 · third_quarter · Q3
Proposed rule on Medicare physician fee schedule for CY 2019, including provisions related to evaluation and management codes
Filing targets: SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2018 · second_quarter · Q2
Efforts to address Affordable Care Act market stabilization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2018 · second_quarter · Q2
S. 204/P.L. 115-176, Right to Try Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2018 · first_quarter · Q1
HR 3325/S 428, ACE Kids Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2018 · first_quarter · Q1
HR 5160, Cancer Care Planning and Communications Act
Filing targets: HOUSE OF REPRESENTATIVES
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2018 · first_quarter · Q1
HR 5247/S 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2017 · fourth_quarter · Q4
Repeal of Affordable Care Act individual mandate in the Tax Cuts and Jobs Act, HR 1 Bipartisan Health Care Stabilization Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2017 · fourth_quarter · Q4
Repeal of the Affordable Care Act individual mandate in the Tax Cuts and Jobs Act, HR 1 Bipartisan Health Care Stabilization Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2017 · fourth_quarter · Q4
Repeal of the Affordable Care Act individual mandate in the Tax Cuts and Jobs Act, HR 1 Bipartisan Health Care Stabilization Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2017 · third_quarter · Q3
HR 1628, American Health Care Act, and Graham-Cassidy amendment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2017 · third_quarter · Q3
HR 1628, American Health Care Act, and Graham-Cassidy amendment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2017 · third_quarter · Q3
HR 1628, American Health Care Act, and Graham-Cassidy Amendment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2017 · second_quarter · Q2
HR 1628, American Health Care Act Better Care Reconciliation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2017 · second_quarter · Q2
HR 1628, American Health Care Act Better Care Reconciliation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2017 · second_quarter · Q2
HR 1628, American Health Care Act Better Care Reconciliation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2017 · first_quarter · Q1
American Health Care Act, HR 1628
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2017 · first_quarter · Q1
American Health Care Act, HR 1628
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2017 · first_quarter · Q1
American Health Care Act, H.R. 1628
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2016 · fourth_quarter · Q4
HR 2846, Planning Actively for Cancer Treatment Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2016 · fourth_quarter · Q4
Affordable Care Act repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2016 · fourth_quarter · Q4
Affordable Care Act Repeal
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2016 · second_quarter · Q2
Fiscal Year 2017 Appropriations for the National Institutes of Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2016 · second_quarter · Q2
Establishment of Oncology Center of Excellence at Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2016 · second_quarter · Q2
HR 2846, Planning Actively for Cancer Treatment Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2016 · first_quarter · Q1
Comments on Senate Finance Committee policy options for chronic care reform.
Filing targets: SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2016 · first_quarter · Q1
FY 2017 funding for National Institutes of Health and Food and Drug Administration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2016 · first_quarter · Q1
Comments on Senate Finance Committee policy options for reform of chronic care.
Filing targets: SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2015 · fourth_quarter · Q4
Funding for the National Institutes of Health and Food and Drug Administration, H.R. 2029, Fiscal Year 2016 Consolidated Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2015 · third_quarter · Q3
21st Century Cures Act, HR 6 Childhood Cancer STAR Act, S 1883 and HR 3381
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2015 · third_quarter · Q3
21st Century Cures Act, HR 6
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANCER LEADERSHIP COUNCIL via TURNER & GOSS LLP
2015 · third_quarter · Q3
21st Century Cures Act, HR 6
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via TURNER & GOSS LLP
2015 · second_quarter · Q2
HR 6, 21st Century Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COALITION FOR CANCER SURVIVORSHIP via TURNER & GOSS LLP
2015 · second_quarter · Q2
Planning Actively for Cancer Treatment Act (HR 2846) and submission of comments to Senate Finance Committee regarding chronic care management in Medicare.
H.R. 6, 21st Century Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYMPHOMA RESEARCH FOUNDATION via TURNER & GOSS LLP
2015 · second_quarter · Q2
Planning Actively for Cancer Treatment (PACT) Act, HR 2846 and submission of comments to Senate Finance Committee in response to request for information on chronic care management in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE